SEC Form 4 · accession 0001104659-16-110362
CATABASIS PHARMACEUTICALS INC · CATB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Burt A Adelman
Director
Period of report
Apr 5, 2016
Accepted (ET)
Apr 7, 2016 · 4:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001454789
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.80 | Apr 5, 2016 | A | 13,000 | A | — | Apr 4, 2026 | Common Stock | 13,000 | 13,000 | D |
Explanation of responses
- F1This option was granted on April 5, 2016. The option is scheduled to vest as to one-third of the shares of common stock underlying the option on each anniversary of the grant date until the third anniversary of the grant date.